HGF and hepatocellular carcinoma: Besides, in vitro and in vivo studies have demonstrated that miR-101-3p inhibits HCC progression by targeting HGF and it could be regarded as another potential therapeutic tool for regulating cell proliferation and metastasis (Liu et al., 2019).